iNDICA NEWS BUREAU-
The US healthcare major Johnson & Johnson has applied for Emergency Use Authorization (EUA) of its single-dose COVID-19 vaccine in India, on Friday August 6, said the company.
The company had earlier said that it remained committed to bringing its single-dose COVID-19 vaccine to India and looks forward to ongoing discussions with the Indian government.
“On August 5, J&J applied for EUA of its single-dose COVID-19 vaccine to the government of India,” a Johnson & Johnson India spokesperson said in a statement.
The development came after reports surfaced that the company has pulled its proposal seeking accelerated approval for local trials in India.
In April, Johnson and Johnson had said that it was seeking approval to conduct a bridging clinical study of its single-dose COVID-19 vaccine candidate Janssen in India.
India has been seeing a slow rise newly infected cases. As many as 44,643 fresh cases disease were registered in the last 24 hours pushing the cumulative tally to 3,18,56,757.
This is the third straight day when the country saw more than 40,000 new cases being registered, while there has been a rise in over 2,000 cases from Thursday’s figures when 42,982 were recorded.
According to the latest update from the Union ministry of health and family welfare, India’s active Covid-19 figures now stand at 4,14,159 constituting 1.29 per cent of the total infections. The daily positivity rate now stands at 2.72 per cent. This has remained below three per cent since the last 11 days.
So far, India has seen 4,26,754 deaths from the viral disease, including 464 loss of lives recorded in the last 24 hours. The fatality rate has now touched 1.34 percent. Also, 41,096 patients recovered from the virus during the same period, taking the total tally of discharges to 31,015,844, the updated bulletin read. With this recovery rate is now at 97.37 percent.
The Indian Council of Medical Research (ICMR) said 47,65,33,650 samples have been tested for the virus since the pandemic hit the country. Of these, 16,40,287 tests were conducted on Thursday, August 5.
In this case the additional vaccine from J&J could help the country manage the spread of the virus and could possibly help it to progress it to new devastating waves.
